P

Inventor

MADISON VINCENT S

US37 patents
⚠️ This page may combine multiple inventors who share the name “MADISON VINCENT S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING CORP

25 patents
US7504424B2Mar 17, 2009

Compounds for the treatment of inflammatory disorders

SCHERING CORP24 citations92
US7488745B2Feb 10, 2009

Compounds for the treatment of inflammatory disorders

SCHERING CORP23 citations92
US7482370B2Jan 27, 2009

Compounds for the treatment of inflammatory disorders

SCHERING CORP20 citations92
US6894072B2May 17, 2005

Compounds as NS3-serine protease inhibitors of hepatitis C virus

SCHERING CORP59 citations92
US7687527B2Mar 30, 2010

Compounds for the treatment of inflammatory disorders

SCHERING CORP8 citations84
US7968683B1Jun 28, 2011

Factor IXa crystals, related complexes and methods

SCHERING CORP7 citations82
US7683085B2Mar 23, 2010

Compounds for the treatment of inflammatory disorders

SCHERING CORP6 citations74
US7879890B2Feb 1, 2011

Compounds for the treatment of inflammatory disorders

SCHERING CORP6 citations73
US7700773B2Apr 20, 2010

4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2H-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors

SCHERING CORP3 citations63
US7553864B2Jun 30, 2009

Compounds for the treatment of inflammatory disorders and microbial diseases

SCHERING CORP2 citations62
US7208311B2Apr 24, 2007

Catalytic domain of ADAM33 and methods of use thereof

SCHERING CORP4 citations61
US7638513B2Dec 29, 2009

Compounds for the treatment of inflammatory disorders

SCHERING CORP6 citations60
US7776589B1Aug 17, 2010

Polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3)

SCHERING CORP2 citations58
US7335758B2Feb 26, 2008

Catalytic domain of ADAM33 and methods of use thereof

SCHERING CORP0 citations51
US7285408B2Oct 23, 2007

Crystalline form of an n231 mutant catalytic domain of ADAM33 and methods of use thereof

SCHERING CORP0 citations51
US8034907B2Oct 11, 2011

Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides

SCHERING CORP0 citations49
US7785879B1Aug 31, 2010

Pregnane X receptor compositions, crystals and uses thereof

SCHERING CORP0 citations49
US7632920B2Dec 15, 2009

Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof

SCHERING CORP0 citations49
US7888474B2Feb 15, 2011

HDM2 polypeptides

SCHERING CORP0 citations48
US7705127B1Apr 27, 2010

HDM2 Polypeptides

SCHERING CORP0 citations48
US8048663B2Nov 1, 2011

Crystal of pregnane X receptor fused to steroid receptor coactivator-1

SCHERING CORP0 citations47
US7824491B2Nov 2, 2010

Method for crystallizing aurora 2 kinase catalytic domain polypeptide

SCHERING CORP0 citations47
US7422885B1Sep 9, 2008

Crystalline form of the catalytic domain of Aurora 2 kinase and methods of use thereof

SCHERING CORP0 citations47
US7459296B2Dec 2, 2008

Hepatitis C virus NS3 helicase subdomain I

SCHERING CORP0 citations46
US7511063B2Mar 31, 2009

High affinity quinoline-based kinase ligands

SCHERING CORP0 citations39

HOFFMANN LA ROCHE

7 patents

GUZI TIMOTHY J

1 patent

COOPER ALAN B

1 patent

BEYER BRIAN M

1 patent

FISCHMANN THIERRY O

1 patent

PRONGAY ANDREW J

1 patent